NEVVI Medicare utilization intelligence

← back

SAEED, ZABILAMD NPI 1578084232 Clinician

Hematology-Oncology · NORTON SHORES, MI

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 16 years since medical school (class of 2010, self-reported to CMS)
Location NORTON SHORES, MI · NPPES registered location
Active in data Billed Medicare 2021–2024 (3 years)
Scale 38 codes billed · 10,509 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20222026
CANCER AND HEMATOLOGY CENTERS OF WESTERN MI, P.C.
2024–2026
VIDANT MEDICAL GROUP LLC
2022

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2023-08

Year: 2024 · 2022  · 2021 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0461 Injection, atropine sulfate, 0.01 mg
J9190 Injection, fluorouracil, 500 mg
J2469 Injection, palonosetron hcl, 25 mcg
J0640 Injection, leucovorin calcium, per 50 mg
J9206 Injection, irinotecan, 20 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
96375 Injection of additional new drug or substance into vein
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
83735 Magnesium level
96372 Injection of drug or substance under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
96416 Administration of prolonged chemotherapy into vein
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
82378 Carcinoembryonic antigen (cea) protein level
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J7030 Infusion, normal saline solution , 1000 cc
96361 Infusion into a vein for hydration, each additional hour
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J1200 Injection, diphenhydramine hcl, up to 50 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96360 Infusion into a vein for hydration, 31-60 minutes
96374 Injection of drug or substance into vein
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
86704 Hepatitis b core antibody measurement
86706 Hepatitis b surface antibody measurement
87340 Detection test by immunoassay technique for hepatitis b surface antigen
96523 Irrigation of implanted venous access drug delivery device
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.